Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

BACKGROUND: Validated biomarkers to evaluate HIV-1 cure strategies are currently lacking, therefore requiring analytical treatment interruption (ATI) in study participants. Little is known about the safety of ATI and its long-term impact on patient health. OBJECTIVES: ATI safety was assessed and pot...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Antimicrob Chemother
Asıl Yazarlar: De Scheerder, Marie-Angélique, Van Hecke, Clarissa, Zetterberg, Henrik, Fuchs, Dietmar, De Langhe, Nele, Rutsaert, Sofie, Vrancken, Bram, Trypsteen, Wim, Noppe, Ytse, Van Der Gucht, Bea, Pelgrom, Jolanda, Van Wanzeele, Filip, Palmer, Sarah, Lemey, Philippe, Gisslén, Magnus, Vandekerckhove, Linos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7869780/
https://ncbi.nlm.nih.gov/pubmed/32053203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller